Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study

Harshita Rajasekariah, Georgia McCaughan, Chun Kei Kris Ma, Natasha Gorrie, Samuel Milliken, David Ma, Keith Fay, Barbara Withers, Nada Hamad, Samuel Birch, Anne Keogh, Andrew Jabbour, Christopher Hayward, Peter Macdonald, John Moore

Blood (2023) 142 (Supplement 1): 3414.

https://doi.org/10.1182/blood-2023-184319

Published: 2023

Journal Articles

Optimizing Viable CD34 + Enumeration in Cryopreserved HPC Samples for Implementation of an External QA Program - Relevance to the Current Pandemic

Scott J Ragg, Annabella Chang, David Ma

Blood (2021) 138 (Supplement 1): 4847.

https://doi.org/10.1182/blood-2021-154444

Published: 2021

Journal Articles

Potential Benefits of a 6-Week Exercise and Mindfulness-Based Telehealth Training for HCT Survivors to Meet the Challenges of the COVID-19 Pandemic - a Feasibility Study

David Ma, David Kliman, Kate Fennessy, Nikki Molan

Blood (2021) 138 (Supplement 1): 4045.

https://doi.org/10.1182/blood-2021-152350

Published: 2021

Journal Articles

Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index

Jacinta Perram, Eleni Mayson, Catherine Tang, Steven Tran, Donna Aarons, Anthony J Dodds, Keith Fay, Nada Hamad, David Ma, Sam Milliken, Barbara Withers, Matthew Greenwood, William S Stevenson, Christopher Kevin Arthur, Ian H Kerridge, John Moore

Blood (2021) 138 (Supplement 1): 3958.

https://doi.org/10.1182/blood-2021-147106

Published: 2021

Journal Articles

Inhibition of microRNA 10a, an Autophagy Modulator, Increases Chemosensitivity to Ara-C in Acute Myeloid Leukemia

Thi T. Vu, PhD, Friedrich Stoelzel, MD, Gerhard Ehninger, Tim Molloy, David Ma

Blood (2017) 130 (Supplement 1): 3795.

https://doi.org/10.1182/blood.V130.Suppl_1.3795.3795

Published: 2017

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) — a Phase II Clinical Trial

Jennifer Massey, MBBS, John Moore, MDFRACP,FRCPA,, Ian Sutton, Chun Kei Kris Ma, PhDMBBS, Sam Milliken, FRACP,FRCPA,MBBS, David Ma

Blood (2017) 130 (Supplement 1): 4553.

https://doi.org/10.1182/blood.V130.Suppl_1.4553.4553

Published: 2017

Journal Articles

Mir-10a Regulates Autophagy and Cell Cycle in Normal Karyotype Acute Myeloid Leukaemia

Timothy J Molloy, PhD, Thi T Vu, PhD, Friedrich Stölzel, MD, Gerhard Ehninger, MD, David Ma, MD

Blood (2016) 128 (22): 2862.

https://doi.org/10.1182/blood.V128.22.2862.2862

Published: 2016

Journal Articles

Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Relapsing after Autologous Stem Cell Transplantation (ASCT): An Analysis of Patients Included in the Coral Study

Eric Van Den Neste, MD PhD, Norbert Schmitz, MD, Nicolas Mounier, MD PhD, Devinder Gill, MB FRCPath FRACP FRCPA, Marek Trneny, MD, PhD, Prof., Noel Milpied, John A. Radford, MD, Nicolas Ketterer, Ofer Shpilberg, MD, Ulrich Dührsen, David Ma, MD, Josette Briere, Catherine Thieblemont, Gilles A. Salles, MD PhD, Craig Moskowitz, MD, Bertran Glass, Christian Gisselbrecht

Blood (2015) 126 (23): 517.

https://doi.org/10.1182/blood.V126.23.517.517

Published: 2015

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) Patients Failing Second-Line R-DHAP Or R-ICE Chemotherapy Included In The Coral Study

Eric Van Den Neste, MD, PhD, Christian Gisselbrecht, MD, Norbert Schmitz, Nicolas Mounier, MD, PhD, Devinder S Gill, David Linch FMedSci, Marek Trneny, MD, Ph.D.,, Noel Milpied, MD, PhD, John Radford, MD, Nicolas Ketterer, Ofer Shpilberg, MD, MPH, Ulrich Dührsen, MD, David Ma, MD, Josette Brière, MD, Catherine Thieblemont, MD, PhD, Gilles Andre Salles, MD, PhD, Craig H. Moskowitz, MD, Bertram Glass

Blood (2013) 122 (21): 764.

https://doi.org/10.1182/blood.V122.21.764.764

Published: 2013

Journal Articles

MicroRNA Expression in Acute Myeloid Leukaemia and Their Effects on the Differentiation of Acute Myeloid Leukaemia Cells

Catalina A Palma, PhD, Elise Tonna, Adam J Bryant, Vivek Jayaswal, PhD, David Agapiou, Yee Hwa Yang, David Ma, MD, Mark Lutherborrow, PhD

Blood (2011) 118 (21): 2430.

https://doi.org/10.1182/blood.V118.21.2430.2430

Published: 2011

Journal Articles

Knockdown of MicroRNA-10a in Acute Myeloid Leukaemia Cells Bearing the Nucleophosmin1 Mutation Causes Cell Death and Reduced Clonogenicity

Adam J Bryant, Catalina A Palma, PhD, Mark Lutherborrow, PhD, Vivek Jayaswal, PhD, Yee Hwa Yang, David Ma, MD

Blood (2011) 118 (21): 1367.

https://doi.org/10.1182/blood.V118.21.1367.1367

Published: 2011

Journal Articles

Independent Predictive Value of PET-CT Pre Transplant in Relapsed and Refractory Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Included in the CORAL Study.

Marek Trneny, MD, Andre Bosly, MD, PhD, Krimo Bouabdallah, MD, David Ma, MD, Ofer Shpilberg, MD, MPH, Silvia Montoto, MD, Catherine Sebban, MD, Hans Hagberg, M.D., Craig H Moskowitz, MD, Norbert Schmitz, MD, PhD, Christian Gisselbrecht, MD

Blood (2009) 114 (22): 881.

https://doi.org/10.1182/blood.V114.22.881.881

Published: 2009

Journal Articles

Early Dose-Escalation in Chronic Myeloid Leukaemia Patients with Low Plasma Imatinib Levels Leads to Equivalent BCR-ABL Values and Drug Levels at 6 Months to Those with Optimal Drug Levels: First Analysis From the TIDEL II Trial of De-Novo Patients Treated with 600mg Imatinib.

Michael P Osborn, Deborah L White, PhD, Verity A Saunders, Bronwyn Cambareri, Susan Branford, PhD, Andrew Menelaou, Bereha Khodr, PhD, Cassandra Slader, Mark Hertzberg, Anthony Schwarer, David Ma, MD, Christopher Arthur, Cecily J. Forsyth, Samar Issa, Yiu Lam Kwan, John Taper, Andrew Grigg, Timothy P. Hughes, MD

Blood (2009) 114 (22): 1131.

https://doi.org/10.1182/blood.V114.22.1131.1131

Published: 2009

Journal Articles

R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study.

Christian Gisselbrecht, MD, Norbert Schmitz, MD, Nicolas Mounier, MD, PhD, David Ma, MD, Marek Trneny, MD, Hans Hagberg, MD, David C. Linch, MD, Ofer Shpilberg, MD, Nicolas Ketterer, MD, Bertram Glass, MD, Andre Bosly, MD, Devinder Gill, MD, Philippe Gaulard, MD, Craig Moskowitz, MD

Blood (2007) 110 (11): 517.

https://doi.org/10.1182/blood.V110.11.517.517

Published: 2007

Journal Articles

A Matched Pair Retrospective Comparison of Adult Unrelated and Sibling Donor Allogeneic Transplantation for AML.

John J. Moore, MBBS, FRACP, FRCPA, Ken B. Bradstock, MBBS, FRACP, FRCPA, Anthony Dodds, MBBS, PhD, FRACP, Jeff Szer, MBBS, FRCPA, FRACP, Ian Nivison Smith, BSc, Kim Goh, MBBS, MRCP, David Ma, MBBS, FRACP, FRCPA

Blood (2004) 104 (11): 5173.

https://doi.org/10.1182/blood.V104.11.5173.5173

Published: 2004

NARROW

Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study

Optimizing Viable CD34 + Enumeration in Cryopreserved HPC Samples for Implementation of an External QA Program - Relevance to the Current Pandemic

Potential Benefits of a 6-Week Exercise and Mindfulness-Based Telehealth Training for HCT Survivors to Meet the Challenges of the COVID-19 Pandemic - a Feasibility Study

Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index

Inhibition of microRNA 10a, an Autophagy Modulator, Increases Chemosensitivity to Ara-C in Acute Myeloid Leukemia

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) — a Phase II Clinical Trial

Mir-10a Regulates Autophagy and Cell Cycle in Normal Karyotype Acute Myeloid Leukaemia

Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Relapsing after Autologous Stem Cell Transplantation (ASCT): An Analysis of Patients Included in the Coral Study

Diffuse Large B-Cell Lymphoma (DLBCL) Patients Failing Second-Line R-DHAP Or R-ICE Chemotherapy Included In The Coral Study

MicroRNA Expression in Acute Myeloid Leukaemia and Their Effects on the Differentiation of Acute Myeloid Leukaemia Cells

Knockdown of MicroRNA-10a in Acute Myeloid Leukaemia Cells Bearing the Nucleophosmin1 Mutation Causes Cell Death and Reduced Clonogenicity

Independent Predictive Value of PET-CT Pre Transplant in Relapsed and Refractory Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Included in the CORAL Study.

Early Dose-Escalation in Chronic Myeloid Leukaemia Patients with Low Plasma Imatinib Levels Leads to Equivalent BCR-ABL Values and Drug Levels at 6 Months to Those with Optimal Drug Levels: First Analysis From the TIDEL II Trial of De-Novo Patients Treated with 600mg Imatinib.

R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study.

A Matched Pair Retrospective Comparison of Adult Unrelated and Sibling Donor Allogeneic Transplantation for AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only